ArticleScience advances2018
Prepublication disclosure of scientific results: Norms, competition, and commercial orientation.
Article in Science advances, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Are researchers allowed to publicly disseminate research findings before journal publication?Journal of medical ethics and history of medicine · 2025Article
- Estimating social bias in data sharing behaviours: an open science experiment.Scientific data · 2023Article
- Conservatism Gets Funded? A Field Experiment on the Role of Negative Information in Novel Project Evaluation.Management science · 2022Article
- Social Media and the Dissemination of Prepublication Data in Surgical Fields.Plastic and reconstructive surgery. Global open · 2019Article
- Promises and perils of gene drives: Navigating the communication of complex, post-normal science.Proceedings of the National Academy of Sciences of the United States of America · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
On the basis of a survey of 7103 active faculty researchers in nine fields, we examine the extent to which scientists disclose prepublication results, and when they do, why? Except in two fields, more scientists disclose results before publication than not, but there is significant variation in their reasons to disclose, in the frequency of such disclosure, and in withholding crucial results when making public presentations. They disclose results for feedback and credit and to attract collaborators. Particularly in formulaic fields, scientists disclose to attract new researchers to the field independent of collaboration and to deter others from working on their exact problem. A probability model shows that 70% of field variation in disclosure is related to differences in respondent beliefs about norms, competition, and commercialization. Our results suggest new research directions-for example, do the problems addressed or the methods of scientific production themselves shape norms and competition? Are the levels we observe optimal or simply path-dependent? What is the interplay of norms, competition, and commercialization in disclosure and the progress of science?
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.